DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
-3.27%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.01B
AUM Growth
+$262M
(+4.6%)
Cap. Flow
-$204M
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159
Top Buys
| 1 |
WAY
Waystar Holding Corp
WAY
|
$106M |
| 2 |
Gilead Sciences
GILD
|
$102M |
| 3 |
CVS Health
CVS
|
$57.6M |
| 4 |
Baxter International
BAX
|
$52.6M |
| 5 |
Cullinan Oncology
CGEM
|
$37.4M |
Top Sells
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$136M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$80.7M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$63.2M |
| 4 |
Oscar Health
OSCR
|
$38.2M |
| 5 |
Viking Therapeutics
VKTX
|
$38M |
Sector Composition
| 1 | Healthcare | 83.29% |
| 2 | Industrials | 0.67% |
| 3 | Technology | 0.57% |
| 4 | Financials | 0.44% |
| 5 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Otis Worldwide
OTIS
$34.1B
| $313K | 0.01% |
+3,248
| New | +$313K |
|
327
Mesa Laboratories
MLAB
$356M
| $311K | 0.01% |
+3,581
| New | +$311K |
|
328
Braze
BRZE
$3.5B
| $311K | 0.01% |
+7,995
| New | +$311K |
|
329
Trinity Industries
TRN
$2.31B
| $310K | 0.01% |
10,376
+1,047
| +11% | +$31.3K |
|
330
Extreme Networks
EXTR
$2.87B
| $310K | 0.01% |
+23,026
| New | +$310K |
|
331
American Eagle Outfitters
AEO
$3.26B
| $306K | 0.01% |
15,316
+3,460
| +29% | +$69.1K |
|
332
Relay Therapeutics
RLAY
$710M
| $304K | 0.01% |
+46,702
| New | +$304K |
|
333
Molina Healthcare
MOH
$9.47B
| $303K | 0.01% |
+1,020
| New | +$303K |
|
334
Pulmonx
LUNG
$70.9M
| $301K | 0.01% |
47,539
+27,250
| +134% | +$173K |
|
|
LENZ
335
LENZ Therapeutics
LENZ
$1.2B
| $300K | 0.01% |
+17,353
| New | +$300K |
|
336
Lockheed Martin
LMT
$108B
| $300K | 0.01% |
+642
| New | +$300K |
|
337
Option Care Health
OPCH
$4.72B
| $300K | 0.01% |
+10,816
| New | +$300K |
|
338
F5
FFIV
$18.1B
| $296K | ﹤0.01% |
+1,720
| New | +$296K |
|
339
Amicus Therapeutics
FOLD
$2.46B
| $295K | ﹤0.01% |
29,752
+13,263
| +80% | +$132K |
|
340
Krystal Biotech
KRYS
$4.35B
| $295K | ﹤0.01% |
+1,605
| New | +$295K |
|
341
First Industrial Realty Trust
FR
$6.92B
| $292K | ﹤0.01% |
+6,152
| New | +$292K |
|
342
Woodward
WWD
$14.6B
| $287K | ﹤0.01% |
1,648
+185
| +13% | +$32.3K |
|
343
Mercury Systems
MRCY
$4.13B
| $285K | ﹤0.01% |
+10,569
| New | +$285K |
|
344
CarMax
KMX
$9.11B
| $285K | ﹤0.01% |
3,881
+1,474
| +61% | +$108K |
|
345
Quanterix
QTRX
$211M
| $284K | ﹤0.01% |
+21,461
| New | +$284K |
|
346
Peloton Interactive
PTON
$3.27B
| $281K | ﹤0.01% |
+83,256
| New | +$281K |
|
347
Waste Connections
WCN
$46.1B
| $281K | ﹤0.01% |
+1,603
| New | +$281K |
|
348
Addus HomeCare
ADUS
$2.08B
| $279K | ﹤0.01% |
+2,407
| New | +$279K |
|
349
Akero Therapeutics
AKRO
$3.58B
| $278K | ﹤0.01% |
11,867
-1,778
| -13% | -$41.7K |
|
350
Corpay
CPAY
$22.4B
| $277K | ﹤0.01% |
+1,039
| New | +$277K |
|